These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7867309)

  • 1. Evaluation of 80% inhibition standards for the determination of fluconazole minimum inhibitory concentrations in three laboratories.
    Espinel-Ingroff A; Steele-Moore L; Galgiani JN
    Diagn Microbiol Infect Dis; 1994 Oct; 20(2):81-6. PubMed ID: 7867309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of fluconazole minimum inhibitory concentrations in three different formulations of RPMI-1640.
    Espinel-Ingroff A; Steele-Moore L
    Diagn Microbiol Infect Dis; 1994 Oct; 20(2):87-91. PubMed ID: 7867310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
    To WK; Fothergill AW; Rinaldi MG
    J Clin Microbiol; 1995 Oct; 33(10):2660-4. PubMed ID: 8567901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard.
    Barchiesi F; Colombo AL; McGough DA; Rinaldi MG
    J Clin Microbiol; 1994 Oct; 32(10):2494-500. PubMed ID: 7814488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts.
    Arthington-Skaggs BA; Motley M; Warnock DW; Morrison CJ
    J Clin Microbiol; 2000 Jun; 38(6):2254-60. PubMed ID: 10834985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method.
    Pfaller MA; Barry AL
    Mycopathologia; 1995; 130(1):3-9. PubMed ID: 7666925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the minimum inhibitory concentration of Cryptococcus neoformans and Cryptococcus gattii against fluconazole by flow cytometry.
    Morales BP; Junior IN; Trilles L; Bertho AL; Oliveira Rde V; Nishikawa MM; Elias Mdos S; Wanke B; Lazéra Mdos S
    Med Mycol; 2014 Jan; 52(1):90-8. PubMed ID: 23808405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
    Warnock DW; Johnson EM; Rogers TR
    J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of culture media on in vitro susceptibility testing of fluconazole against some yeasts.
    Sekhon AS; Garg AK; Hamir Z
    Mycoses; 1991; 34(7-8):319-22. PubMed ID: 1803235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans.
    Krishnarao TV; Galgiani JN
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1957-60. PubMed ID: 9303393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commercial systems for fluconazole susceptibility testing of yeasts: comparison with the broth microdilution method.
    Posteraro B; Romano L; Sanguinetti M; Masucci L; Morace G; Fadda G
    Diagn Microbiol Infect Dis; 2000 Sep; 38(1):29-36. PubMed ID: 11025181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.
    Pfaller MA; Barry AL
    J Clin Microbiol; 1994 Aug; 32(8):1992-6. PubMed ID: 7989555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique.
    Chen SC; O'Donnell ML; Gordon S; Gilbert GL
    J Antimicrob Chemother; 1996 Feb; 37(2):265-73. PubMed ID: 8707736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
    Fujita S
    Rinsho Byori; 1996 Apr; 44(4):373-8. PubMed ID: 8847821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: an eight-center collaborative study.
    Anaissie EJ; Paetznick VL; Ensign LG; Espinel-Ingroff A; Galgiani JN; Hitchcock CA; LaRocco M; Patterson T; Pfaller MA; Rex JH; Rinaldi MG
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2387-91. PubMed ID: 8891149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2862-4. PubMed ID: 11557481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine.
    Pfaller MA; Bale M; Buschelman B; Lancaster M; Espinel-Ingroff A; Rex JH; Rinaldi MG; Cooper CR; McGinnis MR
    J Clin Microbiol; 1995 May; 33(5):1104-7. PubMed ID: 7615713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibilities of Candida and Cryptococcus neoformans isolates from blood cultures of neutropenic patients.
    Hoban DJ; Zhanel GG; Karlowsky JA
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1463-4. PubMed ID: 10348771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a new commercial colorimetric microdilution method with a standard method for in-vitro susceptibility testing of Candida spp. and Cryptococcus neoformans.
    Davey KG; Szekely A; Johnson EM; Warnock DW
    J Antimicrob Chemother; 1998 Oct; 42(4):439-44. PubMed ID: 9818741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.